Pharmacological Effects of Astragaloside IV: A Review

Pharmacological Effects of Astragaloside IV: A Review

Astragaloside IV (AS-IV) is one of the main active components extracted from the Chinese medicinal herb Astragali and serves as a marker for assessing the herb’s quality. AS-IV is a tetracyclic triterpenoid saponin in the form of lanolin ester alcohol and exhibits various biological activities. This...

Full description

Bibliographic Details
Main Authors:	Yutong Liang, Biqiong Chen, Di Liang, Xiaoxiao Quan, Ruolan Gu, Zhiyun Meng, Hui Gan, Zhuona Wu, Yunbo Sun, Shuchen Liu, Guifang Dou
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Molecules
Subjects:	astragaloside IV anti-inflammatory antioxidative neuroprotective antifibrotic antitumor
Online Access:	https://www.mdpi.com/1420-3049/28/16/6118

Similar Items

Astragaloside IV, as a potential anticancer agent
by: Dongqin Xia, et al.
Published: (2023-02-01)

Astragalosidic Acid: A New Water-Soluble Derivative of Astragaloside IV Prepared Using Remarkably Simple TEMPO-Mediated Oxidation
by: Lin-Sen Qing, et al.
Published: (2017-07-01)

Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV
by: Zehui Xu, et al.
Published: (2023-12-01)

Astragaloside IV alleviates lipopolysaccharide‐induced preeclampsia‐like phenotypes via suppressing the inflammatory responses
by: Dilihuma Tuerxun, et al.
Published: (2021-03-01)

Network Pharmacology and Experimental Evidence Identify the Mechanism of Astragaloside IV in Oxaliplatin Neurotoxicity
by: Xu J, et al.
Published: (2021-01-01)

Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function
by: Chuang Sun, et al.
Published: (2021-07-01)

Research progress of astragaloside IV in the treatment of atopic diseases
by: Shencun Yu, et al.
Published: (2022-12-01)

Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress
by: Chunlan Ji, et al.
Published: (2018-09-01)

Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
by: Mei-Ling Xia, et al.
Published: (2020-04-01)

Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis
by: Lu-Yun Qin, et al.
Published: (2022-03-01)

The Mechanism Actions of Astragaloside IV Prevents the Progression of Hypertensive Heart Disease Based on Network Pharmacology and Experimental Pharmacology
by: Haoran Jing, et al.
Published: (2021-11-01)

The Effect of Astragaloside IV on Isoproterenol-Induced Myocardial Infarction in Rats
by: Fatemeh Fathizad, et al.
Published: (2019-06-01)

The potential molecular pathways of Astragaloside-IV in colorectal cancer: A systematic review
by: Tang Ziyang, et al.
Published: (2023-11-01)

Astragaloside IV Improves Metabolic Syndrome and Endothelium Dysfunction in Fructose-Fed Rats
by: Feng Zhao, et al.
Published: (2011-05-01)

Integrating Network Pharmacology and Experimental Validation to Explore the Pharmacological Mechanism of Astragaloside IV in Treating Bleomycin-Induced Pulmonary Fibrosis
by: Yuan S, et al.
Published: (2023-04-01)

Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
by: Tan YQ, et al.
Published: (2020-09-01)

Astragaloside-IV Alleviates Heat-Induced Inflammation by Inhibiting Endoplasmic Reticulum Stress and Autophagy
by: Zhiwei Dong, et al.
Published: (2017-06-01)

Astragaloside IV Exerts Cardioprotection in Animal Models of Viral Myocarditis: A Preclinical Systematic Review and Meta-Analysis
by: Zhuang Zhuang, et al.
Published: (2019-11-01)

In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis
by: Chenliang Ge, et al.
Published: (2020-09-01)

Review on the protective mechanism of astragaloside IV against cardiovascular diseases
by: Chunkun Yang, et al.
Published: (2023-05-01)

The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease
by: Yiwei Gao, et al.
Published: (2023-07-01)

Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
by: Tan J, et al.
Published: (2023-07-01)

Astragaloside IV-enhanced anti-hepatocarcinoma immunity of dendritic cells
by: Hongxing Guo, et al.
Published: (2022-05-01)

Mechanism of Astragaloside Ⅳ on HepG2 Cells Based on Molecular Dynamics Simulation and Experimental Evaluation
by: ZHOU Zhipeng, et al.
Published: (2022-07-01)

Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII
by: Wanting Qin, et al.
Published: (2024-02-01)

The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications
by: Li L, et al.
Published: (2023-03-01)

Protective effect of Astragaloside IV against sepsis-induced acute lung injury in rats
by: Ruiqin Huang, et al.
Published: (2016-05-01)

Research Progress on the Ability of Astragaloside IV to Protect the Brain Against Ischemia-Reperfusion Injury
by: Xianhui Kang, et al.
Published: (2021-11-01)

Astragaloside IV promotes angiogenesis by targeting SIRT7/VEGFA signaling pathway to improve brain injury after cerebral infarction in rats
by: Zhijie Ou, et al.
Published: (2023-12-01)

Astragaloside IV Protects Ethanol-Induced Gastric Mucosal Injury by Preventing Mitochondrial Oxidative Stress and the Activation of Mitochondrial Pathway Apoptosis in Rats
by: Shumin Qin, et al.
Published: (2019-08-01)

Astragaloside IV: A promising natural neuroprotective agent for neurological disorders
by: Min Yao, et al.
Published: (2023-03-01)

Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway
by: Xujun You, et al.
Published: (2024-04-01)

Astragaloside IV regulates autophagy-mediated proliferation and apoptosis in a rat model of PCOS by activating the PPARγ pathway
by: Mingxiao Wen, et al.
Published: (2022-07-01)

Astragaloside IV Prevents Cardiac Remodeling in the Apolipoprotein E-Deficient Mice by Regulating Cardiac Homeostasis and Oxidative Stress
by: Xiong-Zhi Li, et al.
Published: (2017-12-01)

Calcium Sensing Receptor-Related Pathway Contributes to Cardiac Injury and the Mechanism of Astragaloside IV on Cardioprotection
by: Meili Lu, et al.
Published: (2018-10-01)

Astragaloside IV Inhibits the Proliferation of Human Uterine Leiomyomas by Targeting IDO1
by: Tiantian Qiu, et al.
Published: (2022-09-01)

Extraction Optimization of Astragaloside IV by Response Surface Methodology and Evaluation of Its Stability during Sterilization and Storage
by: Lin Xu, et al.
Published: (2021-04-01)

Astragaloside IV improves the pharmacokinetics of febuxostat in rats with hyperuricemic nephropathy by regulating urea metabolism in gut microbiota
by: Zhen Xiong Zhao, et al.
Published: (2022-12-01)

Evaluation and Comparison of the Inhibition Effect of Astragaloside IV and Aglycone Cycloastragenol on Various UDP-Glucuronosyltransferase (UGT) Isoforms
by: Ruixue Ran, et al.
Published: (2016-11-01)

Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling
by: Fei Xu, et al.
Published: (2018-08-01)